Study of the Bruton's Tyrosine Kinase Inhibitor in Subjects With Chronic Graft Versus Host Disease

Emory University, Winship Cancer Institute, Atlanta

Vanderbilt University Medical Center, Henry-Joyce Cancer Clinic, Nashville

Ohio State University Comprehensive Cancer Center, Columbus

University of Minnesota, Minneapolis

Washington University School of Medicine, St Louis

City of Hope Medical Center, Duarte

University of California, San Francisco, San Francisco

Stanford University, Stanford

Fred Hutchinson Cancer Research Center, Seattle

Dana Farber Cancer Institute, Boston